PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7635967-2	1995	Administration of fenofibrate (300 mg/d) to 16 patients with coronary artery disease resulted in a marked increase in plasma apo A-II concentrations (0.34 +/- 0.11 to 0.45 +/- 0.17 grams/liter; P < 0.01).	Fenofibrate	18-29	NLR family pyrin domain containing 3	Homo sapiens	129-133	
7635967-5	1995	Transient transfection experiments of a reporter construct driven by the human apo A-II gene promoter indicated that fenofibrate induced apo A-II gene expression at the transcriptional level.	Fenofibrate	117-128	NLR family pyrin domain containing 3	Homo sapiens	83-87	
2653621-4	1989	Fenofibrate also affected the structure and composition of some of the major classes of lipoproteins: increases in apolipoproteins (apo) AI and AII and decreases in apo B and apo E were consistent with reductions in TG, VLDL, and LDL and increases in HDL.	Fenofibrate	0-11	NLR family pyrin domain containing 3	Homo sapiens	144-147